Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

January 31, 2007

Conditions
Asthma
Interventions
DRUG

IPL512,602 20 mg once daily

DRUG

IPL512,602 Matching Placebo once daily

Trial Locations (8)

53792

University of Wisconsin - Madison, Madison

90025

Allergy Research Foundation, Inc., Los Angeles

90806

West Coast Clinical Trials, Long Beach

92123

Asthma Medical Group & Resarch, San Diego

95128

San Jose Clinical Research, San Jose

97231

Allergy Associates Research Center, Portland

97504

Clinical Research Institute of South Oregaon, Medford

02743

Northeast Medical Research Associates, Inc, No. Dartmouth

Sponsors
All Listed Sponsors
lead

Inflazyme Pharmaceuticals Ltd

INDUSTRY